> ## Content Index
> Fetch the complete content index at: https://members.americanhealthintel.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Rock Health finds digital health M&A hit busiest quarter since 2021
- URL: https://members.americanhealthintel.com/2026-07-20-ledger/
- Published: 2026-07-20T16:02:22.000Z
- Updated: 2026-07-20T16:02:22.000Z
- Description: Plus: XRHealth acquires fibromyalgia digital therapeutic maker Swing Therapeutics. The day's rules, money, and enforcement, sourced and tiered below.
- Author: American Health Intel

Plus: XRHealth acquires fibromyalgia digital therapeutic maker Swing Therapeutics. The day's rules, money, and enforcement, sourced and tiered below.

| American Health Intel Rules · Money · Medicine · Decoded daily The Ledger Monday, July 20, 2026 Rock Health finds digital health M&A hit busiest quarter since 2021 Plus: XRHealth acquires fibromyalgia digital therapeutic maker Swing Therapeutics. The day's rules, money, and enforcement, sourced and tiered below. ![](https://americanhealthintel.com/email/pulse-divider.png) Report Confidence: High Digital health startups, the tech companies building software and devices for hospitals, doctors and patients, just had their busiest acquisition quarter since 2021, even as venture funding stayed modest. Rock Health found $7.4 billion raised across 244 deals in H1 2026, but 115 acquisitions closed, 71 in the second quarter alone, the most active quarter since late 2021\. Mega deals over $100 million took 45% of all capital. Why it matters This is a snapshot of how much money and dealmaking is happening in digital health right now, useful for gauging whether the sector is consolidating. Watch whether acquisitions keep outrunning new funding rounds through the second half of 2026. Sources: [Rockhealth](https://rockhealth.com/insights/h1-2026-funding-and-market-overview-durable-roots-shifting-routes/?ref=members.americanhealthintel.com) Deal Confidence: High XRHealth, a digital therapeutics platform for chronic conditions, just bought Swing Therapeutics, maker of the first FDA-authorized digital treatment for fibromyalgia, which affects 10 million Americans. XRHealth's 6th acquisition in 2 years brings Stanza, a program validated in a Lancet-published Phase 3 trial, plus Swing Care, a virtual clinic where 88% of patients reported improved wellbeing at one year. Terms undisclosed. Why it matters This adds a new treatment option for fibromyalgia, a condition affecting an estimated 10 million Americans, to a platform already covered by Medicare Part B, the VA and commercial insurance. Watch whether XRHealth expands Stanza's reach beyond its current 22-state footprint. Sources: [Prweb](https://www.prweb.com/releases/xrhealth-acquires-swing-therapeutics-expanding-its-platform-to-mobile-digital-therapeutics-302822708.html?ref=members.americanhealthintel.com) Also today Cross Country Healthcare stockholders approve $437M Knox Lane take-private [Read](https://americanhealthintel.com/editions/2026-07-20-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#cross-country-healthcare-knox-lane-stockholder-vote) Medical office building investment hits multiyear high as Big Sky Medical buys San Antonio campus [Read](https://americanhealthintel.com/editions/2026-07-20-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition#big-sky-medical-ridgewood-mob-frontier-scan) 181Records$16.0BEnforcement7Deadlines65Rules [Read this issue + the trackers](https://americanhealthintel.com/editions/2026-07-20-ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) Pick your field on the site and every story tells you what it means for you. Reply to this email and tell us what you want covered. We read everything. We show our work. We score our own calls. [Track record](https://americanhealthintel.com/ledger/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Calendar](https://americanhealthintel.com/calendar/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [Enforcement](https://americanhealthintel.com/enforcement/?utm%5Fsource=newsletter&utm%5Fmedium=email&utm%5Fcampaign=edition) · [X](https://x.com/amhealthintel?ref=members.americanhealthintel.com) · [LinkedIn](https://www.linkedin.com/company/american-health-intel?ref=members.americanhealthintel.com) News and analysis, not legal, medical, coding, or investment advice.You subscribed at americanhealthintel.com · [Unsubscribe](%%{unsubscribe%5Furl}%%) |
| --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |